The company’s pipeline includes investigational, preclinical and clinical stage anti-resistance agents based on novel mechanisms of action that include efflux pump inhibition and modulation of ...

After that, I moved to the University of Birmingham and I’ve never left! I did a PhD on how efflux pumps contribute to antibiotic resistance in Gram-negative bacteria, followed by a postdoc ...

This paper presents the important discovery that lipid metabolic imbalance caused by Snail, an EMT-related transcription factor, contributes to the acquisition of chemoresistance in cancer cells.